3rd Edition of International Heart Congress
June 05-07,2025 | Hybrid Event
Reperfusion Therapy
Reperfusion therapy is a crucial medical intervention designed to restore blood flow to tissues or organs after a period of reduced or blocked circulation, typically observed in conditions such as heart attacks or strokes. The primary goal of reperfusion is to salvage endangered tissue by swiftly re-establishing the oxygen and nutrient supply. This therapeutic approach is often employed in the context of myocardial infarctions, where timely intervention can minimize cardiac damage and improve outcomes. Various reperfusion strategies exist, including the administration of clot-busting medications or the use of catheter-based procedures to reopen blocked vessels. Despite its life-saving potential, the effectiveness of reperfusion therapy hinges on swift diagnosis and prompt implementation, underscoring its critical role in the realm of cardiovascular and neurological care.
Shuping Zhong
University of Southern California, United States
Yong Xiao Wang
Albany Medical Center, United States
Yochai Birnbaum
Baylor College of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Thomas Bernd Dschietzig
Relaxera GmbH & Co. KG, Germany
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian Federation
Narendra Kumar
HeartbeatsZ Academy, United KingdomSubmit your abstract Today
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain